Related Experiment Video
Updated: May 28, 2025

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
Published on: October 6, 2023
Bee venom: Yesterday's enemy becomes modern medicine for skin cancer
Amr Ahmed El-Arabey1, Hamed A Ghramh2
1Applied College, King Khalid University, P.O. Box 9004, Abha, 61413, Saudi Arabia; Center of Bee Research and its Products, King Khalid University, P.O. Box 9004, Abha, 61413, Saudi Arabia; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, 11751, Egypt.
Abstract:
Malignant melanoma is one of the most lethal human malignancies, particularly when it spreads from its initial site in the skin to distant locations with few therapeutic options. While a range of treatment approaches exist, such as chemotherapy, radiation, immunotherapy, and targeted therapy, they typically fail to treat skin cancer, particularly in its late stages. The complex cellular and molecular mechanisms that drive melanoma growth and metastatic dissemination are both varied and complicated, posing significant challenges to the development of effective treatment approaches. As the incidence and burden of this malignancy increase, there is an urgent need for innovative therapeutic techniques. Therefore, it is vital to research alternate therapy options. Several research undertaken in recent years have found that bee venom influences a variety of cancers. The more research into using bee venom to cure skin cancer, the less attention it receives. In this context, the purpose of this proposal is to review a comprehensive assessment of the clinical impact of bee venom against skin cancer, as well as to highlight challenges and excitement down the road.
Insights
Bee venom shows potential in treating malignant melanoma, a lethal skin cancer. Further research is needed to explore its clinical impact and overcome challenges in developing this novel therapy.
Area of Science:
- Oncology
- Dermatology
- Toxicology
Background:
- Malignant melanoma is a deadly skin cancer with limited treatment options, especially in advanced stages.
- Current therapies like chemotherapy and immunotherapy often fail due to complex cancer mechanisms.
- There is a critical need for innovative treatments to combat rising melanoma incidence.
Purpose of the Study:
- To comprehensively review the clinical impact of bee venom on skin cancer.
- To explore bee venom as a potential alternative therapy for malignant melanoma.
- To identify challenges and future directions for bee venom in cancer treatment.
Main Methods:
- Literature review of existing research on bee venom and cancer.
- Analysis of studies investigating bee venom's effects on melanoma cells and models.
- Assessment of clinical data, where available, on bee venom therapy for skin cancer.
Main Results:
- Preliminary research suggests bee venom possesses anti-cancer properties affecting various malignancies.
- Specific studies indicate bee venom components may inhibit melanoma growth and metastasis.
- However, clinical evidence and research specifically on bee venom for skin cancer remain limited.
Conclusions:
- Bee venom presents a promising, yet under-explored, therapeutic avenue for malignant melanoma.
- Further rigorous research is essential to validate its efficacy and safety for skin cancer treatment.
- Addressing current research gaps will pave the way for novel bee venom-based therapies.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Applications of Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

